Tandem Diabetes Care Inc (TNDM) - Medical Equipment - Deals and Alliances Profile
- GDME45129D
- Pages: 52
- October 2018
- Total Views:1148
- Region : North America
- GlobalData
- Equity Research Report
Details
Summary
Tandem Diabetes Care Inc (Tandem) is a medical device company that designs, develops and manufactures diabetic care products. The company provides products such as t:slim X2 insulin pump, t:slim G4 insulin pump, t:flex insulin pump, t:simulator demo app, software and apps, t:connect application and tandem device updater, among others. It utilizes micro-delivery and color touchscreen technologies. Tandem also provides infusion set, which is a 90° flexible soft cannula. The company offers a wide range of accessories and supplies to help its clients to further customize their systems. It markets its products through its distribution network. Tandem is headquartered in San Diego, California, the US.
Tandem Diabetes Care Inc (TNDM)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table Of Content
Scope
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Tandem Diabetes Care Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Tandem Diabetes Care Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Tandem Diabetes Care Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Tandem Diabetes Care Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Tandem Diabetes Care Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Tandem Diabetes Care Inc, Medical Equipment, Deal Details 11
Asset Purchase 11
Tandem Diabetes Care Acquires US Patents And Patent Applications From Smiths Medical 11
Venture Financing 12
Tandem Diabetes Care Raises USD 36.4 Million In Series D Financing 12
Partnerships 13
Tandem Diabetes Care Enters into Licensing Agreement with TypeZero Technologies 13
Tandem Expands Licensing Agreement With Dexcom For Glucose Monitoring System 14
Tandem Diabetes Amends Licensing Agreement With DexCom 15
Tandem Diabetes Care Enters into Co-Development Agreement with Dexcom 16
Tandem Diabetes Enters Into Co-Development Agreement With JDRF For Dual-Chamber Infusion Pump 17
Equity Offering 18
Tandem Diabetes Care Rises USD115 Million in Public Offering of Shares 18
Tandem Diabetes Care Raises USD69 Million in Public Offering of Shares 19
Tandem Diabetes Care Plans to Raise USD10.7 Million in Public Offering of Securities 20
Tandem Diabetes Care Prices Public Offering of Shares for USD16.2 Million 21
Tandem Diabetes Care Plans to Raise up to USD15 Million in Public Offering of Shares 23
Tandem Diabetes Care Raises USD23 Million in Public Offering of Shares 24
Tandem Diabetes Raises USD69.4 Million in Public Offering of Shares 26
Tandem Diabetes Care Completes IPO For USD 138 Million 28
Tandem Diabetes Care Inc-Key Competitors 30
Tandem Diabetes Care Inc-Key Employees 31
Tandem Diabetes Care Inc-Locations And Subsidiaries 32
Head Office 32
Recent Developments 33
Financial Announcements 33
Jul 30, 2018: Tandem Diabetes Care Reports Second Quarter 2018 Financial Results 33
Apr 26, 2018: Tandem Diabetes Care Reports First Quarter 2018 Financial Results 34
Apr 10, 2018: Tandem Diabetes Care Announces Preliminary First Quarter 2018 Results 35
Mar 01, 2018: Tandem Diabetes Care Announces 2017 Financial Results 36
Jan 09, 2018: Tandem Diabetes Care Announces Preliminary 2017 Results and Provides 2018 Guidance 38
Oct 26, 2017: Tandem Diabetes Care Reports Third Quarter 2017 Financial Results 39
Jul 27, 2017: Tandem Diabetes Care Reports Second Quarter 2017 Financial Results 41
Apr 27, 2017: Tandem Diabetes Care Reports First Quarter 2017 Financial Results 42
Mar 08, 2017: Tandem Diabetes Care Reports 2016 Financial Results 44
Corporate Communications 46
Dec 07, 2017: Tandem Diabetes Care CFO to Retire, Successor Named 46
Product News 47
Dec 14, 2017: Tandem Diabetes Care Announces Issuance of Patent Related to Automated Insulin Delivery Technology 47
Aug 24, 2017: Tandem Diabetes Care Announces Issuance of Patent Related to Remote Bolus Feature for Medical Infusion Pumps 48
Aug 08, 2017: Tandem Diabetes Care Announces Issuance of Patent Related to Important Safety Features for Portable Infusion Pumps that Utilize Touchscreen Control 49
Feb 15, 2017: Data Presented at ATTD 2017 Demonstrate Clinical Advantages of Tandem Diabetes Care Sensor-augmented Pump over Medtronic MiniMed SAPs 50
Other Significant Developments 51
Jan 03, 2018: Tandem Diabetes Care Commences Full Manufacturing Operations at New San Diego Facility 51
Appendix 52
Methodology 52
About GlobalData 52
Contact Us 52
Disclaimer 52
List Of Figure
List of Figures
Tandem Diabetes Care Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Tandem Diabetes Care Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Tandem Diabetes Care Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Tandem Diabetes Care Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Tandem Diabetes Care Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Tandem Diabetes Care Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Tandem Diabetes Care Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Tandem Diabetes Care Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9
List Of Table
List of Tables
Tandem Diabetes Care Inc, Medical Equipment, Key Facts, 2017 2
Tandem Diabetes Care Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Tandem Diabetes Care Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Tandem Diabetes Care Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Tandem Diabetes Care Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Tandem Diabetes Care Inc, Deals By Market, 2012 to YTD 2018 9
Tandem Diabetes Care Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Tandem Diabetes Care Acquires US Patents And Patent Applications From Smiths Medical 11
Tandem Diabetes Care Raises USD 36.4 Million In Series D Financing 12
Tandem Diabetes Care Enters into Licensing Agreement with TypeZero Technologies 13
Tandem Expands Licensing Agreement With Dexcom For Glucose Monitoring System 14
Tandem Diabetes Amends Licensing Agreement With DexCom 15
Tandem Diabetes Care Enters into Co-Development Agreement with Dexcom 16
Tandem Diabetes Enters Into Co-Development Agreement With JDRF For Dual-Chamber Infusion Pump 17
Tandem Diabetes Care Rises USD115 Million in Public Offering of Shares 18
Tandem Diabetes Care Raises USD69 Million in Public Offering of Shares 19
Tandem Diabetes Care Plans to Raise USD10.7 Million in Public Offering of Securities 20
Tandem Diabetes Care Prices Public Offering of Shares for USD16.2 Million 21
Tandem Diabetes Care Plans to Raise up to USD15 Million in Public Offering of Shares 23
Tandem Diabetes Care Raises USD23 Million in Public Offering of Shares 24
Tandem Diabetes Raises USD69.4 Million in Public Offering of Shares 26
Tandem Diabetes Care Completes IPO For USD 138 Million 28
Tandem Diabetes Care Inc, Key Competitors 30
Tandem Diabetes Care Inc, Key Employees 31
Licence Rights
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
Section Purchase
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products and Companies
Products
Tandem Diabetes Care Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Company Profile
Company Profile Title
Summary
Tandem Diabetes Care Inc (Tandem) is a medical device company that designs, develops and manufactures diabetic care products. The company provides products such as t:slim X2 insulin pump, t:slim G4 insulin pump, t:flex insulin pump, t:simulator demo app, software and apps, t:connect application and tandem device updater, among others. It utilizes micro-delivery and color touchscreen technologies. Tandem also provides infusion set, which is a 90° flexible soft cannula. The company offers a wide range of accessories and supplies to help its clients to further customize their systems. It markets its products through its distribution network. Tandem is headquartered in San Diego, California, the US.
Tandem Diabetes Care Inc (TNDM)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Scope
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Tandem Diabetes Care Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Tandem Diabetes Care Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Tandem Diabetes Care Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Tandem Diabetes Care Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Tandem Diabetes Care Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Tandem Diabetes Care Inc, Medical Equipment, Deal Details 11
Asset Purchase 11
Tandem Diabetes Care Acquires US Patents And Patent Applications From Smiths Medical 11
Venture Financing 12
Tandem Diabetes Care Raises USD 36.4 Million In Series D Financing 12
Partnerships 13
Tandem Diabetes Care Enters into Licensing Agreement with TypeZero Technologies 13
Tandem Expands Licensing Agreement With Dexcom For Glucose Monitoring System 14
Tandem Diabetes Amends Licensing Agreement With DexCom 15
Tandem Diabetes Care Enters into Co-Development Agreement with Dexcom 16
Tandem Diabetes Enters Into Co-Development Agreement With JDRF For Dual-Chamber Infusion Pump 17
Equity Offering 18
Tandem Diabetes Care Rises USD115 Million in Public Offering of Shares 18
Tandem Diabetes Care Raises USD69 Million in Public Offering of Shares 19
Tandem Diabetes Care Plans to Raise USD10.7 Million in Public Offering of Securities 20
Tandem Diabetes Care Prices Public Offering of Shares for USD16.2 Million 21
Tandem Diabetes Care Plans to Raise up to USD15 Million in Public Offering of Shares 23
Tandem Diabetes Care Raises USD23 Million in Public Offering of Shares 24
Tandem Diabetes Raises USD69.4 Million in Public Offering of Shares 26
Tandem Diabetes Care Completes IPO For USD 138 Million 28
Tandem Diabetes Care Inc-Key Competitors 30
Tandem Diabetes Care Inc-Key Employees 31
Tandem Diabetes Care Inc-Locations And Subsidiaries 32
Head Office 32
Recent Developments 33
Financial Announcements 33
Jul 30, 2018: Tandem Diabetes Care Reports Second Quarter 2018 Financial Results 33
Apr 26, 2018: Tandem Diabetes Care Reports First Quarter 2018 Financial Results 34
Apr 10, 2018: Tandem Diabetes Care Announces Preliminary First Quarter 2018 Results 35
Mar 01, 2018: Tandem Diabetes Care Announces 2017 Financial Results 36
Jan 09, 2018: Tandem Diabetes Care Announces Preliminary 2017 Results and Provides 2018 Guidance 38
Oct 26, 2017: Tandem Diabetes Care Reports Third Quarter 2017 Financial Results 39
Jul 27, 2017: Tandem Diabetes Care Reports Second Quarter 2017 Financial Results 41
Apr 27, 2017: Tandem Diabetes Care Reports First Quarter 2017 Financial Results 42
Mar 08, 2017: Tandem Diabetes Care Reports 2016 Financial Results 44
Corporate Communications 46
Dec 07, 2017: Tandem Diabetes Care CFO to Retire, Successor Named 46
Product News 47
Dec 14, 2017: Tandem Diabetes Care Announces Issuance of Patent Related to Automated Insulin Delivery Technology 47
Aug 24, 2017: Tandem Diabetes Care Announces Issuance of Patent Related to Remote Bolus Feature for Medical Infusion Pumps 48
Aug 08, 2017: Tandem Diabetes Care Announces Issuance of Patent Related to Important Safety Features for Portable Infusion Pumps that Utilize Touchscreen Control 49
Feb 15, 2017: Data Presented at ATTD 2017 Demonstrate Clinical Advantages of Tandem Diabetes Care Sensor-augmented Pump over Medtronic MiniMed SAPs 50
Other Significant Developments 51
Jan 03, 2018: Tandem Diabetes Care Commences Full Manufacturing Operations at New San Diego Facility 51
Appendix 52
Methodology 52
About GlobalData 52
Contact Us 52
Disclaimer 52
List Of Figure
List of Figures
Tandem Diabetes Care Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Tandem Diabetes Care Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Tandem Diabetes Care Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Tandem Diabetes Care Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Tandem Diabetes Care Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Tandem Diabetes Care Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Tandem Diabetes Care Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Tandem Diabetes Care Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9
List Of Table
List of Tables
Tandem Diabetes Care Inc, Medical Equipment, Key Facts, 2017 2
Tandem Diabetes Care Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Tandem Diabetes Care Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Tandem Diabetes Care Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Tandem Diabetes Care Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Tandem Diabetes Care Inc, Deals By Market, 2012 to YTD 2018 9
Tandem Diabetes Care Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Tandem Diabetes Care Acquires US Patents And Patent Applications From Smiths Medical 11
Tandem Diabetes Care Raises USD 36.4 Million In Series D Financing 12
Tandem Diabetes Care Enters into Licensing Agreement with TypeZero Technologies 13
Tandem Expands Licensing Agreement With Dexcom For Glucose Monitoring System 14
Tandem Diabetes Amends Licensing Agreement With DexCom 15
Tandem Diabetes Care Enters into Co-Development Agreement with Dexcom 16
Tandem Diabetes Enters Into Co-Development Agreement With JDRF For Dual-Chamber Infusion Pump 17
Tandem Diabetes Care Rises USD115 Million in Public Offering of Shares 18
Tandem Diabetes Care Raises USD69 Million in Public Offering of Shares 19
Tandem Diabetes Care Plans to Raise USD10.7 Million in Public Offering of Securities 20
Tandem Diabetes Care Prices Public Offering of Shares for USD16.2 Million 21
Tandem Diabetes Care Plans to Raise up to USD15 Million in Public Offering of Shares 23
Tandem Diabetes Care Raises USD23 Million in Public Offering of Shares 24
Tandem Diabetes Raises USD69.4 Million in Public Offering of Shares 26
Tandem Diabetes Care Completes IPO For USD 138 Million 28
Tandem Diabetes Care Inc, Key Competitors 30
Tandem Diabetes Care Inc, Key Employees 31
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products
Tandem Diabetes Care Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Ask A Question
Our Team Will Assist You in What You Are Looking For
or 
: +91 98100 26150
: ankurgupta1984
Related Reports
Page 179 | 
February 2020
Page 116 | January 2020
Page 235 | January 2020
Page 183 | September 2019
Page 244 | August 2019